ICD-10-CM 2027 diagnosis code
Z15.068Genetic susceptibility to other malignant neoplasm of digestive system
Z15.068 is a valid, billable ICD-10-CM code for genetic susceptibility to other malignant neoplasm of digestive system. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.Short description: Genetic susceptibility to other malig neoplasm of dgstv sys
Code last changed in FY2026 (effective October 1, 2025). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About Z15.068
Z15.068 is the ICD-10-CM diagnosis code for genetic susceptibility to other malignant neoplasm of digestive system. It belongs to category Z15 (genetic susceptibility to disease), block Z14-Z15 (genetic carrier and genetic susceptibility to disease) and chapter 21 (factors influencing health status and contact with health services). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.
Within Z15.06, choose Z15.068 (other malignant neoplasm of digestive system) only when documentation doesn't support a more specific option: colorectal cancer (Z15.060).
Use an additional code, if applicable, for any associated family history of the disease (Z80-Z84).
It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.
In MS-DRG v44.0, it is part of the grouping logic for DRG 951 (Other Factors Influencing Health Status, relative weight 0.5577), in MDC 23 (Factors Influencing Health Status and Other Contacts with Health Services), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.
It is not acceptable as the principal diagnosis for an inpatient stay; it may be reported as a secondary diagnosis.
It is exempt from present-on-admission (POA) reporting, so no POA indicator is required.
It was added in FY2026, effective October 1, 2025.
Coding notes
- Genetic susceptibility to biliary tract cancer
- Genetic susceptibility to gastric cancer
- Genetic susceptibility to pancreatic cancer
- Genetic susceptibility to small bowel cancer
Notes that apply from higher levels
Instructions written at a parent level also apply to Z15.068.
Broader instructions also apply from Chapter 21: Factors influencing health status and contact with health services.
Alphabetic index entries
4 entriesTerms in the official ICD-10-CM index that lead to Z15.068.
- Genetic › susceptibility to disease NEC › malignant neoplasm › biliary tract
- Genetic › susceptibility to disease NEC › malignant neoplasm › digestive system NEC
- Genetic › susceptibility to disease NEC › malignant neoplasm › gastric
- Genetic › susceptibility to disease NEC › malignant neoplasm › pancreas
MS-DRG v44.0 grouping
All DRGs →Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.
MDC 23 · Factors Influencing Health Status and Other Contacts with Health Services
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2026 (effective 10/1/2025): Added
- No changes since FY2026.
Common questions about Z15.068
Is Z15.068 billable?
- Yes. Z15.068 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).
Can Z15.068 be used as a principal diagnosis?
- No. It is not acceptable as the principal diagnosis for an inpatient stay; it may be reported as a secondary diagnosis.
Is Z15.068 a CC or MCC?
- No. Z15.068 is neither a CC nor an MCC under MS-DRG v44.0.
What DRG does Z15.068 group to?
- Z15.068 is used in the MS-DRG v44.0 logic for MS-DRG 951 (Other Factors Influencing Health Status). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.